There is also a full, ad-free video podcast of this broadcast available on True Pundit’s Patreon Page and/or True Pundit’s SubscribeStar.com page for our subscribers to help us do what we do.
Biden Unveils $6 Trillion Budget That Will Raise Federal Spending To Highest Post-WW2 Level – US stock futures soared Thursday morning as President Biden unveiled his first federal budget, which calls for the government to spend $6 trillion in the 2022 fiscal year, with total annual spending set to increase to $8.2 trillion by 2031.
Stocks initially kneejerked higher, then retreated on the headlines reporting the proposed budget, which Biden can pass through the Senate using budget rules that allow Dems to circumvent the filibuster. According to the NYT, it calls for the highest sustained levels of federal spending since World War II. – READ MORE
Just 6% Of Small Businesses Have Fully Recovered Pandemic Losses, Poll Shows – Just 6% of small businesses that were negatively impacted by the coronavirus pandemic have fully recovered their losses, a Job Creators Network survey showed.
The vast majority of U.S. small business owners continue to “claw their way out” of the hole caused by the coronavirus pandemic, according to the poll commissioned by small business advocacy group Job Creators Network (JCN) and shared with the Daily Caller News Foundation. While 6% of small business owners that suffered losses related to the pandemic said they have recovered, 43% believed they would be fully recovered within six months. – READ MORE
Mild coronavirus infection leaves behind lasting antibody protection, research suggests – Even a mild case of coronavirus could leave people with lifelong protection against the virus, a new study suggests, with researchers calling previous reports that immunity was not long-lived following infection “a misinterpretation of the data.”
In the study, conducted by Washington University School of Medicine in St. Louis and published May 24 in the journal Nature, researchers took bone marrow samples from 18 out of 77 participants who were already signed up to give blood samples at three-month intervals starting about a month after initial infection. The bone marrow samples were taken between seven and eight months after initial COVID infection. Five of the 18 participants then gave second bone marrow samples four months later. – READ MORE
Microsoft president: Orwell’s 1984 could happen in 2024 – Life as depicted in George Orwell’s 1984 “could come to pass in 2024” if lawmakers don’t protect the public against artificial intelligence, Microsoft’s president has warned.
Speaking to BBC’s Panorama, Brad Smith said it will be “difficult to catch up” with the rapidly advancing technology. – READ MORE
Life Insurance & COVID-19; Something Doesn’t Make Sense – You would think that during the worst Pandemic since the 1918 Spanish Flu life insurance companies would be hedging their bets to avoid major losses from Covid-19.
I haven’t written a life policy for several years so I was wondering what was going on?
I called one of the brokers I deal with that interacts with hundreds of big life insurers to get an inside look into how the Covid crisis has changed their business. – READ MORE
“I Don’t Know Of A Bigger Story In The World” Right Now Than Ivermectin: NYTimes Best-Selling Author – Michael Capuzzo, a New York Times best-selling author , has just published an article titled “The Drug That Cracked Covid”. The 15-page article chronicles the gargantuan struggle being waged by frontline doctors on all continents to get ivermectin approved as a Covid-19 treatment, as well as the tireless efforts by reporters, media outlets and social media companies to thwart them.
Because of ivermectin, Capuzzo says, there are “hundreds of thousands, actually millions, of people around the world, from Uttar Pradesh in India to Peru to Brazil, who are living and not dying.” Yet media outlets have done all they can to “debunk” the notion that ivermectin may serve as an effective, easily accessible and affordable treatment for Covid-19. They have parroted the arguments laid out by health regulators around the world that there just isn’t enough evidence to justify its use. – READ MORE